Given the established benefits of GLP-1RAs on cardiovascular outcomes and their favorable effects on atherosclerotic lesion progression, it is plausible to hypothesize that these agents may have a disease-modifying role in patients with T2D undergoing PCI
Presented for research literature review only Jun J (2023)
The FDA states that anti-obesity medication should not be taken while pregnant and should be stopped at least two months before attempting to conceive.
It should be noted that while Ozempic and Mounjaro are officially approved for type 2 diabetes, they are also used off label for weight loss, as clinical trials have consistently shown that both produce significant weight loss as a secondary metabolic benefit
HGF/c-Met Pathway Research It is frequently studied because of its interaction with hepatocyte growth factor signaling pathways associated with neurological research
Systemic anti-inflammatory signaling: TB-500 downregulates inflammatory cytokines across multiple tissue types, including muscle, tendon, cardiac, and neural tissue